An estimated 71 million people around the world are chronically infected with hepatitis C virus (HCV), with a large proportion currently being undiagnosed or diagnosed late. There is an urgent need to identify them and link them to care. In this presentation, A/Prof Jeffrey Lazarus of the Faculty of Medicine at University of Barcelona, reviews the current innovative HCV testing initiatives, and the need for tailored, people-centered approaches to ultimately bring testing services closer to patients. …
Cancer Type: Liver
HCV screening in Egypt: key elements of a successful national screening programme
In 2018, the world’s largest HCV screening campaign was initiated in Egypt. Within 7 months following its initiation, 49.5 million people were screened; and 2.2 million HCV-seropositive individuals were referred for evaluation and treatment. In this article, take a closer look at Egypt’s HCV screening program, and learn about the key elements that contributed to its success. …
HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas
The province of Sindh has one of the world’s highest rates of HCV infection and bears the second highest disease burden of both HBV and HCV among all the provinces in Pakistan. Learn from Prof Muhammad Sadik Memon and Dr Zaigham Abbas, two prominent figures in the fight against HCV in Sindh province, about the challenges in diagnosing and treating HCV-related conditions and opportunities to address them. …
HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands
Pakistan has one of the world’s highest rates of HCV infection. It’s no surprise that their healthcare systems face mounting pressure from HCV-related conditions. Learn from Prof Aamir Khan, Head of the Gastroenterology and Hepatology division at Lady Reading Hospital Peshawar, about his efforts to improve HCV care in KPK, Pakistan’s third largest province, including patients from Afghanistan who cross the border to seek treatment at his hospital….
Future therapies for chronic Hepatitis B and the role of diagnostics
Hepatitis B is an important infectious disease problem in the APAC region. Learn from Prof Henry Chan, director of the Center for Liver Health at Chinese University of Hong Kong, about the new diagnostic tools for HBV and how they can fit into the future landscape of HBV treatment. …
The clinical utility of Elecsys GAAD score in the diagnosis of hepatocellular carcinoma
The performance of Elecsys® GAAD score, which includes the parameters of gender, age, alpha-fetoprotein (AFP) and protein induced by Vitamin K absence or antagonists-II (PIVKA-II) in the diagnosis of HCC is elusive. This study aims to address the diagnostic accuracy of HCC using Elecsys GAAD algorithmic score as compared to AFP and PIVKA-II with or without the complementation of sonography.
Huang CF, Sharma A, Yu ML…